About
Droplet IV is a health-tech startup based in Copenhagen, Denmark, founded in 2022. The company focuses on developing an automated medical device designed to flush intravenous (IV) lines between drug administrations. This device aims to enhance patient safety and treatment efficacy by ensuring full delivery of prescribed medications while reducing the risk of drug interactions and minimizing medicine waste. The flagship product, the Droplet IV device, automates the flushing process, addressing a critical nursing task that is often overlooked due to high workloads. By integrating seamlessly into existing hospital procedures and IV systems, the device supports both closed and open systems, helping to reduce microbial contamination risks. Droplet IV has secured over $5 million in funding, including a recent $2 million investment, to support its regulatory progress and plans for a commercial launch in the European Union and United States by 2026. The company is committed to improving patient treatment and nurse workflow through innovative healthcare solutions.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2022
-
Total Funding $2000000
Location
3 Ole Maaloes Vej, Copenhagen, Capital Region of Denmark, Denmark, 2200
